Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Matrifen 12micrograms/hour transdermal patches
0407020A0BEAAAU
|
Matrifen | Fentanyl | Central Nervous System | 25,342 |
|
Matrifen 25micrograms/hour transdermal patches
0407020A0BEABAE
|
Matrifen | Fentanyl | Central Nervous System | 24,976 |
|
Matrifen 50micrograms/hour transdermal patches
0407020A0BEACAF
|
Matrifen | Fentanyl | Central Nervous System | 14,126 |
|
Matrifen 75micrograms/hour transdermal patches
0407020A0BEADAG
|
Matrifen | Fentanyl | Central Nervous System | 6,801 |
|
Matrifen 100micrograms/hour transdermal patches
0407020A0BEAEAH
|
Matrifen | Fentanyl | Central Nervous System | 6,751 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.